GlassScriptPhysician profile
Tarek Hadla
NPI 1568636629
$1,358.60
in general payments reported to CMS, 2019-2025
19 companies · $165 in 2025
The $165 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $166 · 2021: $236 · 2022: $169 · 2023: $136 · 2024: $293 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $384.78 | 2019-2022 | |
| Abbvie INC. | $215.09 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $167.09 | 2022-2024 | Relistor |
| Pacira Therapeutics, INC. | $148.52 | 2019 | |
| Revance Therapeutics, INC. | $143.54 | 2025 | Daxxify |
| Bioventus LLC | $57.01 | 2020-2021 | |
| Spr Therapeutics, INC | $30.11 | 2024 | Sprint Pns System |
| Pfizer INC. | $27.25 | 2021 | |
| Convatec INC. | $27.05 | 2022 | |
| Boston Scientific Corporation | $21.76 | 2025 | Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $20.17 | 2023 | Iovera, Zilretta |
| Nalu Medical, INC. | $20.08 | 2024 | Nalu Neurostimulation System |
| Hydrocision, INC. | $15.43 | 2020 | |
| Horizon Therapeutics Plc | $14.55 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.15 | 2023 | Seglentis |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $13.84 | 2024 | Euflexxa |
| Depuy Synthes Sales INC. | $13.24 | 2023 | Monovisc, Orthovisc |
| Ermi LLC | $12.89 | 2020 | |
| Orthofix Medical, INC. | $12.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarek Hadla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.